Albion Financial Group’s Elevance Health ELV Stock Holding History

Albion Financial Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.1K	Sell	52 -4	-7%	-$1.48K	﹤0.01%	365
2026 Q1	$16.4K	Buy	56 +4	+8%	+$1.31K	﹤0.01%	364
2025 Q4	$18.2K	Hold	52	–	–	﹤0.01%	352
2025 Q3	$16.8K	Hold	52	–	–	﹤0.01%	347
2025 Q2	$20.2K	Hold	52	–	–	﹤0.01%	311
2025 Q1	$22.6K	Hold	52	–	–	﹤0.01%	305
2024 Q4	$19.2K	Buy	52 +43	+478%	+$18K	﹤0.01%	341
2024 Q3	$4.68K	Hold	9	–	–	﹤0.01%	376
2024 Q2	$4.88K	Hold	9	–	–	﹤0.01%	370
2024 Q1	$4.67K	Buy	9 +3	+50%	+$1.49K	﹤0.01%	361
2023 Q4	$2.83K	Hold	6	–	–	﹤0.01%	382
2023 Q3	$2.61K	Hold	6	–	–	﹤0.01%	364
2023 Q2	$2.67K	Hold	6	–	–	﹤0.01%	371
2023 Q1	$2.76K	Hold	6	–	–	﹤0.01%	360
2022 Q4	$3.08K	Hold	6	–	–	﹤0.01%	364
2022 Q3	$3K	Hold	6	–	–	﹤0.01%	371
2022 Q2	$3K	Hold	6	–	–	﹤0.01%	384
2022 Q1	$3K	Sell	6 -6	-50%	-$2.74K	﹤0.01%	443
2021 Q4	$6K	Buy	+12	New	+$5.05K	﹤0.01%	439

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Albion Financial Group's ELV Position: Q2 2026 in Review

Albion Financial Group reduced its Elevance Health (ELV) stake by 7.1% in Q2 2026, selling an estimated $1.48K and leaving 52 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #365.

Albion Financial Group first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $22.6K in Q1 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Albion Financial Group held 52 shares of Elevance Health worth $20.1K as of Q2 2026.
Albion Financial Group sold 4 Elevance Health shares in Q2 2026, an estimated $1.48K.
Elevance Health made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #365 holding.
Albion Financial Group first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
Albion Financial Group's Elevance Health position peaked at $22.6K in Q1 2025.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.